Twist Bioscience (TWST) Capital Expenditures Growth (3y) (2020 - 2026)
Powered by 
Analysis
Twist Bioscience (TWST) Capital Expenditures Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 16.58% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -6.49% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | -0.41% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -5.23% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | -7.41% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -7.83% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | -2.61% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -13.49% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 60.17% |
| 10 | Twist Bioscience | 8.93 Bn | 8.76 Bn | 62.45 Mn | 29.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 29.37% |
| Mar 31, 2026 | -4.49% |
| Dec 31, 2025 | -5.51% |
| Sep 30, 2025 | -8.95% |
| Jun 30, 2025 | -39.13% |
| Mar 31, 2025 | -49.39% |
| Dec 31, 2024 | -43.81% |
| Sep 30, 2024 | -37.21% |
| Jun 30, 2024 | -48.20% |
| Mar 31, 2024 | -58.44% |
| Dec 31, 2023 | -25.41% |
| Sep 30, 2023 | 2.46% |
| Jun 30, 2023 | 16.55% |
| Mar 31, 2023 | 49.00% |
| Dec 31, 2022 | 79.10% |
| Sep 30, 2022 | 61.71% |
| Jun 30, 2022 | 98.81% |
| Mar 31, 2022 | 103.92% |
| Dec 31, 2021 | 88.06% |
| Sep 30, 2021 | 97.69% |